Sign In
Buy CGEN
$2.34
-0.0700 (-2.90%)
At Close: Aug 10, 2026
Stocks That Hit 52-Week Highs On Thursday
02:19pm, Thursday, 16'th Apr 2020
On Thursday morning, 49 companies hit new 52-week highs.
Noteworthy Mentions:
Amazon.com (NASDAQ: AMZN) was the largest firm on a market cap basis to set a new 52-week...
Compugen to Present Data Update on COM701 Phase 1 Clinical Trial at the 2020 AACR Virtual Annual Meeting
11:00am, Tuesday, 14'th Apr 2020
Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that it will present updates on its ongoing Phase 1 clinical tr
Zacks Investment Research Downgrades Compugen (NASDAQ:CGEN) to Hold
10:50am, Sunday, 12'th Apr 2020
Zacks Investment Research cut shares of Compugen (NASDAQ:CGEN) from a buy rating to a hold rating in a report published on Wednesday morning, Zacks.com reports. According to Zacks, “Compugen Ltd. is
Compugen (NASDAQ:CGEN) Upgraded at BidaskClub
10:10am, Sunday, 12'th Apr 2020
BidaskClub upgraded shares of Compugen (NASDAQ:CGEN) from a buy rating to a strong-buy rating in a report issued on Thursday morning, BidAskClub reports. A number of other brokerages have also recentl
Compugen (NASDAQ:CGEN) Upgraded to "Buy" at Zacks Investment Research
10:04am, Tuesday, 07'th Apr 2020
Zacks Investment Research upgraded shares of Compugen (NASDAQ:CGEN) from a hold rating to a buy rating in a research note released on Monday, Zacks.com reports. The brokerage currently has $8.25 price
Compugen Announces First Patient Dosed in COM902 Phase 1 Trial for Patients With Advanced Malignancies
11:00am, Monday, 06'th Apr 2020
Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that the first patient has been dosed in its Phase 1 clinical t
Compugen Announces First Patient Dosed in COM902 Phase 1 Trial for Patients With Advanced Malignancies
12:00am, Monday, 06'th Apr 2020Compugen Ltd. (NASDAQ:CGEN) Shares Sold by Jane Street Group LLC
11:06am, Saturday, 04'th Apr 2020
Jane Street Group LLC reduced its holdings in shares of Compugen Ltd. (NASDAQ:CGEN) by 16.0% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 85,173 shares of the biot
Blair likes Incyte in premarket analyst action
11:53am, Tuesday, 24'th Mar 2020
Compugen (NASDAQ:CGEN) initiated with Buy rating and $16 (156% upside) price target at SunTrust. Shares up 9% premarket.Incyte (NASDAQ:INCY) resumed with Outperform rating at William Blair. Shares u
SunTrust Robinson Humphrey Initiates Coverage On Compugen with Buy Rating, Announces $16 Price Target
12:00am, Tuesday, 24'th Mar 2020Investors Shaken by Coronavirus Sow Seeds of M&A, Financing Slowdown
11:02pm, Monday, 23'rd Mar 2020
The coronavirus pandemic is narrowing the avenues open to biotechs for financing their endeavors, according to some industry veterans. “I think that fear
Compugen Announces Closing of $75 Million Public Offering of Ordinary Shares
11:00am, Tuesday, 17'th Mar 2020
Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced the closing of its previously announced underwritten public off
Medicxi Bolsters and Expands Team with Senior Industry Leaders
08:00am, Tuesday, 17'th Mar 2020
Medicxi, the leading European life sciences investment firm, today announced the appointment of Sanford (Sandy) Zweifach and Paul Sekhri as Venture Partners.
136 Biggest Movers From Yesterday
09:20am, Friday, 13'th Mar 2020
Gainers
Ranger Energy Services, Inc. (NYSE: RNGR) shares rose 44.8% to close at $4.46 on Thursday.
Ampco-Pittsburgh Corporation (NYSE: AP) shares surged 35.6% to close at $3.20...
A Peek Into The Markets: US Stock Futures Down; Dow Futures Plunge Over 1100 Points
10:24am, Thursday, 12'th Mar 2020
Pre-open movers
U.S. stock futures traded lower in early pre-market trade after President Donald Trump suspended travel from Europe, excluding the United Kingdom, for 30 days....
